https://www.marketscreener.com/quote/stock/DIFFUSION-PHARMA-49478154/news/Diffusion-Pharmaceuticals-to-Initiate-Phase-2-Trial-in-Patients-with-Glioblastoma-Multiforme-Incorpo-41096689/?utm_source=telegram&utm_medium=social&utm_campaign=share